Antibe Therapeutics Inc(Pre-Merger) ATBPF

RE:RE:RE:RE:RE:RE:RE:The time is now

[Actuarial]

Mugsy, the only thing I care is whether ATB-346 will be approved by FDA or not. And the most likely result is yes. When ATE has $70M cash in bank prepared for the worst scenario (ATE bring ATB346 alone through Ph3), nothing truly to worry about.

MrMugsy wrote:

Actuarial wrote: The question everyone should ask himself is: would you still hold your shares if there is no deal in 12 months? In light of ATE has not decided on lowest effective dose, a deal is not in sight yet. My view on ATE is long run but not short term speculation. It depends on how you view the fact of a p2/3 being required. negative side: it requires more time and money; positive side: it will bring us safer profile. I see it be strong positive - it is worth for the longer wait. GLTA longs!

MrMugsy wrote:

woundedknee wrote: So Mugsy, I naively wrote a post early this morning wondering why the share price was floundering and admitted that I didn't know. I also stated that at least Dan was not selling his shares and come to find out , HE WAS, along with Walter Macnee. This after going above the 200 day moving average. So we drop right back below the very next day. Maybe Dan should get a salary increase rather than selling shares out of the blue. I do not know What Dan's salary is, but I would imangine it's ample to say the least. This may not be the real reason for the drop, but it doesn't help. Information like this can change a persons view on a company very quickly. Deja Vu all over again.
It's time for a review of leadership imo.

With respect to Dan's share sale ... you're beating a dead horse as we've already been there a bunch.  The only difference would be if you had a chat with Dan and gave us an update.  Much appreciated if you would.

Shares aren't moving on that news  - the shares aren't really moving as volume is almost non-existent.

If you want Dan out ... then vote him out at the AGM.  Don't let me stand in your way - I think you have bigger hurdles in your way than my votes.

Anyway ... the answer is ... we need deals and I think that's what they are working on.  We need excitement to come back and hopefully that's what P3 will offer.  With deals and P3 coming ... we should have what we need for a NASDAQ listing.  If we don't get the deals ... then we wait.

Now you're caught up Wounded !

 

Agreed Actuarial - if there were no deal for 12 months, I would still be here.  Our cash position allows for that option.

But, unless the company has changed their goal, they are still hoping for deals before Phase 3.

Seeing the update recently in the presentation indicates that the focus is on partnering and it relates perfectly with what I heard from Dan in the past and what others have heard from the company over the past few month.

That being said, negotiations are fluid and there is no deal until there's a signed deal (or deals).

All I'm saying is ... the calendar is wide open and anything can happen from here on in.

Watching the share price to see when rumours start flying is likely our best bet of knowing something is afoot.  IMO.